LLY Elliott Wave Analysis
Eli Lilly is a global pharmaceutical company, currently leading the GLP-1 weight loss and diabetes drug revolution.
LLY wave structures during the GLP-1 cycle have been parabolic with extended impulse waves. Drug approval catalysts create sharp wave transitions.
Key levels driven by GLP-1 revenue growth, drug pipeline data, and earnings.
LLY is the healthcare sector bellwether for the current cycle. Its wave structure leads XLV at major turning points.
H4 Wave Count
4-hour timeframe for precise entry timing
Daily Wave Count
Primary trading timeframe structure
Weekly Wave Count
Macro context and trend direction
Fibonacci Targets
Precise price targets from wave structure
Invalidation Levels
Exact price where the count is wrong
Alternative Scenario
What happens if the primary count fails
Get Daily LLY Analysis
Updated before London open, every trading day. H4, Daily, and Weekly wave counts with precise Fibonacci targets.